Title : Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer.

Pub. Date : 2017 Feb

PMID : 27826831






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Conclusions Orteronel 400 mg BID is well tolerated in postmenopausal women, and significantly suppresses serum estrogens and testosterone. orteronel BH3 interacting domain death agonist Homo sapiens